Across 7 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the full record of transactions filed by Suvretta Capital Management, Llc. Director active across 2 companies, notably Benitec Biopharma Inc.. Aggregated, 11 disclosures have been logged. Breakdown: 10 buys · 0 sell. Total volume traded: €28.5m. Activity tracked since 26 September 2024. The latest transaction was disclosed on 4 February 2026 (Acquisition). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Suvretta Capital Management, Llc
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
588,236 shares@ US$1.92993.5% of flowCommon stock, par value $0.0001 per shareSEC:0000899140-24-001042:0
11 of 11 declarations
About Suvretta Capital Management, Llc
SUVRETTA CAPITAL MANAGEMENT, LLC was disclosed in 11 filings in total. Across the 11 most recent sampled filings, all acquisitions, buy volume totals EUR 28543223 between 2024-09-30 and 2026-02-09, and the filings cited concern Benitec Biopharma Inc. and Veradermics, Inc.